Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 10-Q Report Quarterly Report
  2. 424B2 Offering Prospectus
  3. S-3 Offering Registration Statement
  4. 10-Q Report Quarterly Report
  5. 10-K/A Report 10-K/A
  6. 8-K Event Item 5 · Item 7
  7. 10-Q Report Quarterly Report
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. SC 13D/A Stake Beneficial Ownership Report
  10. DEF 14A Proxy Proxy Statement
  11. 10-K Report Annual Report
  12. S-3/A Offering Registration Statement
  13. S-3/A Offering Registration Statement
  14. S-3/A Offering Registration Statement
  15. S-3/A Offering Registration Statement
  16. 10-Q Report Quarterly Report
  17. 10-K/A Report 10-K/A
  18. 10-Q/A Report 10-Q/A
  19. S-3 Offering Registration Statement
  20. SC 13G Stake Amended Statement of Ownership

Page 62 of 65 · 1,298 filings